Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

RxOutlook®

The latest pipeline drug information, trend news, upcoming drug launches and emerging therapies in today’s pharmaceutical market.

3rd Quarter 2026

Key topics in this quarter’s edition include:

  • Asundexian for secondary stroke prevention
  • Bepirovirsen for treatment of chronic hepatitis B
  • Cagrilintide/semaglutide for chronic weight management
  • Foundayo (orforglipron) for treatment of type 2 diabetes

Download PDF

© 2026 Optum, Inc. All rights reserved. Stock photos used.